Home › Medical Options › CAR T-Cell Therapy
CAR T-Cell vs Chemotherapy
— Steal a chance to understand your options
CAR T-cell therapy and conventional chemotherapy represent two fundamentally different approaches to treating cancer. While chemotherapy relies on cytotoxic chemical drugs to destroy rapidly dividing cells, CAR T-cell therapy is a targeted cellular immunotherapy that genetically reprograms a patient's own immune system to hunt down specific cancer markers.
Key differences overview
| Feature | Conventional Chemotherapy | CAR T-Cell Therapy |
|---|---|---|
| Type of Therapy | Systemic chemical drug treatment | Personalized “living” cellular immunotherapy |
| Mechanism | Targets and kills rapidly dividing cells indiscriminately | Reprograms patient's T-cells to target specific surface proteins (e.g., CD19, BCMA) |
| Administration | Repeated cycles over several weeks or months via IV/oral medication | Typically a one-time IV infusion of engineered cells |
| Main Indications | Broad range of cancers (solid tumors and hematologic malignancies) | Primarily specific relapsed/refractory blood cancers (lymphoma, leukemia, multiple myeloma) |
| Treatment Setting | Outpatient infusion clinics or short routine hospital visits | Specialized medical centers; often requires 1–2+ weeks of close inpatient monitoring |
How they work
Chemotherapy
Acts as a broad chemical agent. It interferes with cancer cells' ability to divide and multiply. Because it targets rapidly dividing cells generally, it also impacts normal fast-dividing healthy tissue (e.g., bone marrow, gut lining, hair follicles).
CAR T-cell therapy
A multi-step biological process:
- Extraction: Patient T-cells are harvested via leukapheresis.
- Engineering: T-cells are genetically modified in a specialized lab to add a Chimeric Antigen Receptor (CAR).
- Expansion: Millions of modified CAR T-cells are grown.
- Infusion: Cells are infused back into the patient, where they actively seek, multiply, and destroy cells displaying the target antigen.
Side effect profiles
Chemotherapy: chronic & systemic
- Nausea, vomiting, and loss of appetite
- Hair loss (alopecia)
- Bone marrow suppression (anemia, neutropenia, increased infection risk)
- Fatigue and cumulative organ toxicities (heart, kidney, nerve damage over repeated cycles)
CAR T-cell therapy: acute & immunological
- Cytokine Release Syndrome (CRS): A systemic inflammatory response triggered as the T-cells rapidly expand and attack cancer. Causes high fever, rapid heart rate, low blood pressure, and potential multi-organ stress.
- Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS): Temporary neurological effects including confusion, difficulty speaking, tremor, or encephalopathy.
- On-target/off-tumor effects: Prolonged low antibody levels (B-cell aplasia) requiring immunoglobulin replacement infusions.
This page is for general information only and is not medical advice. Which treatment is suitable depends on the type and stage of cancer and on your overall health; please discuss all options with your oncologist.
Compare other treatments
Cryosurgery
Extreme cold forms an “ice ball” around a tumor under imaging guidance: a local, minimally invasive option for solid, localized tumors.
Compare with chemotherapyInterventional Therapy
Image-guided, minimally invasive techniques, including embolization and ablation, that deliver treatment directly to a specific tumor.
Compare with chemotherapyMicrowave Ablation
A thin antenna delivers microwave heat directly into a small, localized tumor under CT or ultrasound guidance.
Compare with chemotherapyNK Cell Immunotherapy
Uses the body's innate NK immune cells, infused or activated to recognize and kill cancer cells, and generally better tolerated than T-cell therapies.
Compare with chemotherapySeed Implantation
Radioactive seeds placed inside a brain tumor or resection cavity deliver high-dose local radiation, bypassing the blood-brain barrier.
Compare with chemotherapySteal a chance by talking to us
Share with us your thoughts, your questions, or simply where you are today. Tell us how we can support your journey, and we will get back to you.